Page last updated: 2024-08-23

bucindolol and xamoterol

bucindolol has been researched along with xamoterol in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (40.00)	18.2507
2000's	2 (40.00)	29.6817
2010's	1 (20.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Aiyar, N; Disa, J; Mitchell, MP; Naselsky, DP; Ohlstein, EH; Ruffolo, RR; Stadel, JM; Storer, BL; Willette, RN; Yue, TL	1
Carson, PE	1
Aiyar, N; Andreka, P; Bishopric, NH; Ohlstein, EH; Olson, LC; Turner, MS; Webster, KA; Wei, JQ	1
Böhm, M; Dabew, E; Engelhardt, S; Lohse, MJ; Lorenz, K; Maack, C; Schäfers, HJ; Vlaskin, L	1
Baker, JG; Fretwell, L; Gardiner, SM; Hill, SJ; Kemp, P; March, J	1

Reviews

1 review(s) available for bucindolol and xamoterol

Article	Year
Beta-blocker therapy in heart failure: pathophysiology and clinical results. Current problems in cardiology, 1999, Volume: 24, Issue:7 Topics: Adrenergic beta-Antagonists; Aged; Bisoprolol; Carbazoles; Carvedilol; Clinical Trials as Topic; Exercise; Heart Failure; Heart Rate; Hemodynamics; Humans; Imidazoles; Male; Metoprolol; Middle Aged; Propanolamines; Propranolol; Quality of Life; Stroke Volume; Time Factors; Vasodilator Agents; Xamoterol	1999

Article

Year

Beta-blocker therapy in heart failure: pathophysiology and clinical results.

Current problems in cardiology, 1999, Volume: 24, Issue:7

Topics: Adrenergic beta-Antagonists; Aged; Bisoprolol; Carbazoles; Carvedilol; Clinical Trials as Topic; Exercise; Heart Failure; Heart Rate; Hemodynamics; Humans; Imidazoles; Male; Metoprolol; Middle Aged; Propanolamines; Propranolol; Quality of Life; Stroke Volume; Time Factors; Vasodilator Agents; Xamoterol

1999

Other Studies

4 other study(ies) available for bucindolol and xamoterol

Article	Year
In vitro and in vivo characterization of intrinsic sympathomimetic activity in normal and heart failure rats. The Journal of pharmacology and experimental therapeutics, 1999, Volume: 289, Issue:1 Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Animals, Newborn; Bisoprolol; Carbazoles; Carvedilol; Cell Membrane; Cells, Cultured; Cyclic AMP; Decerebrate State; Dose-Response Relationship, Drug; Heart Failure; Heart Rate; Iodocyanopindolol; Ligands; Male; Myocardium; Propanolamines; Radioligand Assay; Rats; Rats, Sprague-Dawley; Xamoterol	1999
Bucindolol displays intrinsic sympathomimetic activity in human myocardium. Circulation, 2002, May-21, Volume: 105, Issue:20 Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Adult; Aged; Animals; Cell Survival; Colforsin; Culture Techniques; Cyclic AMP; Dose-Response Relationship, Drug; Female; Heart; Humans; Intracellular Fluid; Male; Middle Aged; Myocardium; Propanolamines; Rats; Sympathomimetics; Xamoterol	2002
Partial agonist activity of bucindolol is dependent on the activation state of the human beta1-adrenergic receptor. Circulation, 2003, Jul-22, Volume: 108, Issue:3 Topics: Adrenergic beta-1 Receptor Agonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Atrial Function; Heart Atria; Heart Failure; Heart Rate; Humans; In Vitro Techniques; Male; Metoprolol; Mice; Mice, Transgenic; Middle Aged; Myocardial Contraction; Organ Specificity; Propanolamines; Propranolol; Receptors, Adrenergic, beta-1; Species Specificity; Xamoterol	2003
Predicting in vivo cardiovascular properties of β-blockers from cellular assays: a quantitative comparison of cellular and cardiovascular pharmacological responses. FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2011, Volume: 25, Issue:12 Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Cardiovascular Agents; CHO Cells; Cricetinae; Cricetulus; Cyclic AMP; Heart Rate; Humans; Imidazoles; Isoproterenol; Male; Phenoxyacetates; Phenoxypropanolamines; Propanolamines; Rats; Rats, Sprague-Dawley; Vascular Resistance; Xamoterol	2011